Drugs / Injectable PRF
Injectable PRF
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT05841303 | Jul 2023 → Mar 2024 | — | Cairo University | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06964529 | Feb → Jul 2025 | gingival disorder | Inonu University | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT07049549 Comparator | Sep 2019 → Sep 2020 | periodontitis, aggressive | Izmir Katip Celebi University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Injectable PRF | “Other: injectable PRF” NCT05841303 ↗ |
| Known as | i-PRF | “Autologous injectable platelet-rich fibrin (i-PRF) will be prepared from venous blood using low-speed centrifugation and administered subgingivally to the test quadrants...” NCT07049549 ↗ |
| Known as | injectable platelet-rich fibrin | “Autologous injectable platelet-rich fibrin (i-PRF) will be prepared from venous blood using low-speed centrifugation and administered subgingivally to the test quadrants...” NCT07049549 ↗ |
| Route | Other | “I-PRF will be injected on the site with thin gingival phenotype” NCT05841303 ↗ |